Sosei takes £35M stake in MiNA, secures acquisition option
May 04, 2017
Biotechnology | London, UK | Secondary Transaction
Sosei (TKO: 4565) has agreed to invest £35 million in MiNA Therapeutics, receiving in return a 25.6% stake in the British biotech and exclusive rights to acquire MiNA outright in the future for a further £140 million. Founded in 2008, MiNA offers an RNA platform designed to develop new medicines that restore normal function to patients' cells.